Cargando…
A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication
For adoptive cell transfer (ACT) immunotherapy of tumor-reactive T cells, an effective therapeutic outcome depends upon cell dose, cell expansion in vivo through a minimally differentiated phenotype, long term persistence, and strong cytolytic effector function. An incomplete understanding of the bi...
Autores principales: | Zhou, Jing, Bethune, Michael T., Malkova, Natalia, Sutherland, Alexander M., Comin-Anduix, Begonya, Su, Yapeng, Baltimore, David, Ribas, Antoni, Heath, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779691/ https://www.ncbi.nlm.nih.gov/pubmed/29360859 http://dx.doi.org/10.1371/journal.pone.0191634 |
Ejemplares similares
-
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist
por: Parisi, Giulia, et al.
Publicado: (2020) -
Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
por: Homet Moreno, Blanca, et al.
Publicado: (2015) -
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products
por: Nowicki, Theodore S., et al.
Publicado: (2018) -
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
por: von Euw, Erika, et al.
Publicado: (2009) -
Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma
por: Lassen, Amanda, et al.
Publicado: (2014)